Compounds > iotrolan
Page last updated: 2024-10-29

iotrolan and Spinal Diseases

iotrolan has been researched along with Spinal Diseases in 2 studies

iotrolan: nonionic, isotonic contrast medium designed for intrathecal use; RN given refers to cpd without isomeric designation; DL-3-117 refers to stereoisomer; structure given in first source

Spinal Diseases: Diseases involving the SPINE.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hergan, K1
Doringer, W1
Längle, M1
Oser, W1
Bien, S1
Schumacher, M1
Berger, W1
Wenzel-Hora, BI1

Trials

1 trial available for iotrolan and Spinal Diseases

ArticleYear
Iotrolan, a nonionic dimeric contrast medium in myelography.
    Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. Erganzungsband, 1989, Volume: 128

    Topics: Adult; Aged; Clinical Trials as Topic; Contrast Media; Double-Blind Method; Female; Humans; Iodobenz

1989

Other Studies

1 other study available for iotrolan and Spinal Diseases

ArticleYear
Effects of iodinated contrast agents in MR imaging.
    European journal of radiology, 1995, Volume: 21, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Artifacts; Contrast Media; Female; Humans; Iopamidol; Lumbar Vertebr

1995